❓ Dr. Walker asks about access to cannabis for palliative care in WA, referencing UK data. The Minister confirms access is possible via prescription and agrees to consider UK findings for local patient surveys.
AnsweredQoN 345Legislative Council
QuestionView source ↗
CANNABIS — PALLIATIVE CARE
345. Hon Dr BRIAN WALKER to the Leader of the House
representing the Minister for Health:
I refer the minister to recently
released data from the United Kingdom which suggests that as many as 30 per
cent of patients accessing end-of-life hospice care in the UK are using some
form of cannabis-based product to ease them through their palliative care.
(1) What
provision is there for patients to access cannabis products as part of their
palliative care here in Western Australia, and what costs are associated with
such access?
(2) Are there any
figures to suggest how many end-of-life patients in WA are using cannabis,
either through a valid prescription or illicitly due to cost concerns?
(3) Will the
Department of Health take on board these latest UK figures and ensure that, at
the very least, similar canvassing of patients occurs here, allowing us to
broaden our knowledge in this important area of medicine?
345. Hon Dr BRIAN WALKER to the Leader of the House
representing the Minister for Health:
I refer the minister to recently
released data from the United Kingdom which suggests that as many as 30 per
cent of patients accessing end-of-life hospice care in the UK are using some
form of cannabis-based product to ease them through their palliative care.
(1) What
provision is there for patients to access cannabis products as part of their
palliative care here in Western Australia, and what costs are associated with
such access?
(2) Are there any
figures to suggest how many end-of-life patients in WA are using cannabis,
either through a valid prescription or illicitly due to cost concerns?
(3) Will the
Department of Health take on board these latest UK figures and ensure that, at
the very least, similar canvassing of patients occurs here, allowing us to
broaden our knowledge in this important area of medicine?
AnswerView source ↗
I thank the honourable member for
some notice of the question.
(1) Patients can
access cannabis products in WA as a prescription medicine, including as part of
palliative care. Costs are dependent on product, dosage and treatment schedule.
(2) No.
(3) Yes.
some notice of the question.
(1) Patients can
access cannabis products in WA as a prescription medicine, including as part of
palliative care. Costs are dependent on product, dosage and treatment schedule.
(2) No.
(3) Yes.
Explore WA Government Data
Search the full archive in the free dashboard, or query programmatically via API.
Explore more
Government Gazette
Appointments, regulatory notices, planning changes.
Hansard
Debates, questions, speeches and sentiment.
Tabled Papers
Reports and documents tabled in Parliament.
Committees
Committee profiles and recent reports.
Regulations
Subsidiary legislation with filters and summaries.
Bills
Proposed laws and parliamentary progress.
Acts
Current WA legislation and summaries.
Explanatory Memoranda
Bills with EMs (text/PDF) available.
Members
MP profiles, party breakdown and rankings.
Pollie Rankings
Data-driven rankings across 19 categories.
Amendment Chains
Track how schemes and regulations evolve over time.